These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1269212)

  • 1. Regulatory milieu in India.
    Sheth UK
    Clin Pharmacol Ther; 1976 May; 19(5 Pt 2):704-9. PubMed ID: 1269212
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical pharmacology in the United Kingdom.
    Smith RN
    Clin Pharmacol Ther; 1974 Sep; 16(3):605-15. PubMed ID: 4412474
    [No Abstract]   [Full Text] [Related]  

  • 3. Minimum acceptable requirements for introduction and marketing of drugs.
    Lasagna L
    Drugs; 1974; 7(6):409-13. PubMed ID: 4422210
    [No Abstract]   [Full Text] [Related]  

  • 4. Product liability all dressed up American style.
    Smith R
    Br Med J (Clin Res Ed); 1981 May; 282(6275):1535-7. PubMed ID: 6786550
    [No Abstract]   [Full Text] [Related]  

  • 5. Law, medicines and the doctor: a critical look at drug regulation.
    Dukes MN
    Curr Med Res Opin; 1973; 1(10):612-28. PubMed ID: 4778727
    [No Abstract]   [Full Text] [Related]  

  • 6. Present status of clinical pharmacology and of regulatory requirements for preclinical and clinical evaluation of new drugs in Japan.
    Ishizaki T; Sugita M
    Clin Pharmacol Ther; 1974 Sep; 16(3):577-84. PubMed ID: 4415183
    [No Abstract]   [Full Text] [Related]  

  • 7. Trends in boxed warnings and withdrawals for novel therapeutic drugs, 1996 through 2012.
    Cheng CM; Shin J; Guglielmo BJ
    JAMA Intern Med; 2014 Oct; 174(10):1704-5. PubMed ID: 25127107
    [No Abstract]   [Full Text] [Related]  

  • 8. Legal Liability of Generic vs Brand Drug Manufacturers for Inadequate Product Labels.
    Boumil MM; Curfman G
    JAMA; 2018 Aug; 320(6):547-548. PubMed ID: 30039167
    [No Abstract]   [Full Text] [Related]  

  • 9. Industrial research in the quest for new medicines.
    Berde B
    Clin Exp Pharmacol Physiol; 1974; 1(3):183-95. PubMed ID: 4617642
    [No Abstract]   [Full Text] [Related]  

  • 10. A label that could save lives.
    Potterton D
    Nurs Times; 1984 May 2-8; 80(18):16-7. PubMed ID: 6562545
    [No Abstract]   [Full Text] [Related]  

  • 11. Regulating the safety of pharmaceuticals: the FDA, preemption, and the public's health.
    Gostin LO
    JAMA; 2009 May; 301(19):2036-7. PubMed ID: 19454642
    [No Abstract]   [Full Text] [Related]  

  • 12. The Vernacular of Risk--Rethinking Direct-to-Consumer Advertising of Pharmaceuticals.
    Greene JA; Watkins ES
    N Engl J Med; 2015 Sep; 373(12):1087-9. PubMed ID: 26287749
    [No Abstract]   [Full Text] [Related]  

  • 13. Time to take stock of Indian regulatory guidelines regarding drug use in pregnancy and lactation.
    Arora A; Patil A
    Indian J Pharmacol; 2019; 51(2):126-127. PubMed ID: 31142950
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug labeling for teratogenicity: requirements of the U.S. Food and Drug Administration.
    Kelsey FO
    Prog Clin Biol Res; 1985; 163C():155-9. PubMed ID: 3991617
    [No Abstract]   [Full Text] [Related]  

  • 15. [Problems with high-dose estrogen/progestin combinations such as Mestrogen, in India].
    Wolffers I
    Ned Tijdschr Geneeskd; 1988 Jan; 132(1):29-31. PubMed ID: 3352817
    [No Abstract]   [Full Text] [Related]  

  • 16. A regulatory view of the Medicines Act in the United Kingdom.
    Andrews PA; Thompson GM; Ward C
    J Clin Pharmacol; 1984 Jan; 24(1):6-18. PubMed ID: 6368615
    [No Abstract]   [Full Text] [Related]  

  • 17. New law in Germany compensates patients for drug side-effects.
    Orellana C
    Lancet; 2002 Aug; 360(9331):471. PubMed ID: 12241734
    [No Abstract]   [Full Text] [Related]  

  • 18. Unforeseeable adverse drug reactions: who should pay?
    Loveland D
    Med Law; 1985; 4(4):327-36. PubMed ID: 4046760
    [No Abstract]   [Full Text] [Related]  

  • 19. New drug investigations.
    Fowle AS
    Science; 1969 Jan; 163(3865):339. PubMed ID: 5762770
    [No Abstract]   [Full Text] [Related]  

  • 20. Compensation for drug injury: two solutions to an insoluble problem.
    Smith R
    Br Med J (Clin Res Ed); 1981 May; 282(6276):1610-2. PubMed ID: 6786584
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.